Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dragan Micić

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Medicinski Pregled|August 26, 2009
[Obesity and coronary heart disease: the mechanism of atherogenic impact]Dragan Micić, Snezana Polovina
Srpski Arhiv Za Celokupno Lekarstvo|February 20, 2007
[The treatment of metabolic syndrome]Liljana Hastreiter, Dragan Micić
Srpski Arhiv Za Celokupno Lekarstvo|December 25, 2003
[80 years' of internal medicine education at the medical school of the university in Belgrade (1922-2002)]Jovan Micić, Dragan Micić
Medicinski Pregled|November 19, 2002
Effects of ramipril therapy on some components of insulin resistance syndrome in patients with essential hypertensionLjiljana Bojović, Dragan Micić
Medicinski Pregled|March 31, 2011
[The influence of diet with reduction in calorie intake on metabolic syndrome parameters in obese subjects with impaired glucose tolerance]Snezana Polovina, Dragan Micić
Medicinski Pregled|August 26, 2004
[Effects of a one-year weight reduction program and physical activity on obesity and comorbid conditions]Vesna Mijailović, Dragan Micić, Milan Mijailović
Glas. Srpska Akademija Nauka I Umetnosti. Odeljenje Medicinskih Nauka|December 12, 2007
[Ghrelin and sleep]Dragan Micić, Veselinka Susić, Vladimir Kostić
Medicinski Pregled|November 12, 2009
[TRAb determination in newly detected patients with hyperthyroidism and their prognostic importance]Aleksandra Nikolić, Dragan Micić, Dejan Nikolić, et al.
Vojnosanitetski Pregled|August 1, 2015
The Fracture Risk Assessment Tool (FRAX score) in subclinical hyperthyroidismSnefana Polovina, Dragan Micić, Dragana Miljić, et al.
Diabetes Research and Clinical Practice|April 25, 2008
A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylureaMaja D Jesić, Silvija Sajić, Milos M Jesić, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Medicinski Pregled|August 26, 2009
[Obesity and coronary heart disease: the mechanism of atherogenic impact]Dragan Micić, Snezana Polovina
Srpski Arhiv Za Celokupno Lekarstvo|February 20, 2007
[The treatment of metabolic syndrome]Liljana Hastreiter, Dragan Micić
Srpski Arhiv Za Celokupno Lekarstvo|December 25, 2003
[80 years' of internal medicine education at the medical school of the university in Belgrade (1922-2002)]Jovan Micić, Dragan Micić
Medicinski Pregled|November 19, 2002
Effects of ramipril therapy on some components of insulin resistance syndrome in patients with essential hypertensionLjiljana Bojović, Dragan Micić
Medicinski Pregled|March 31, 2011
[The influence of diet with reduction in calorie intake on metabolic syndrome parameters in obese subjects with impaired glucose tolerance]Snezana Polovina, Dragan Micić
Medicinski Pregled|August 26, 2004
[Effects of a one-year weight reduction program and physical activity on obesity and comorbid conditions]Vesna Mijailović, Dragan Micić, Milan Mijailović
Glas. Srpska Akademija Nauka I Umetnosti. Odeljenje Medicinskih Nauka|December 12, 2007
[Ghrelin and sleep]Dragan Micić, Veselinka Susić, Vladimir Kostić
Medicinski Pregled|November 12, 2009
[TRAb determination in newly detected patients with hyperthyroidism and their prognostic importance]Aleksandra Nikolić, Dragan Micić, Dejan Nikolić, et al.
Vojnosanitetski Pregled|August 1, 2015
The Fracture Risk Assessment Tool (FRAX score) in subclinical hyperthyroidismSnefana Polovina, Dragan Micić, Dragana Miljić, et al.
Diabetes Research and Clinical Practice|April 25, 2008
A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylureaMaja D Jesić, Silvija Sajić, Milos M Jesić, et al.
Pageof 3